Aesthetics clinics are seeing sales boom after lockdown eased in New South Wales, with both Silk and Australian Skin Clinics reporting the equivalent of about two-weeks’ worth of trade within the first week.

Silk founder and managing director Martin Perelman singled out the body and injectables categories for strong performance with “exceptional growth” in online sales of the chain’s skincare brands.

“We are pleased with how the business has performed over the first three months of FY22,” he said.

“While Covid lockdowns again held back sales growth as clinics were forced to close, on an adjusted basis we saw strong momentum in key growth categories, resulting in overall positive like-for-like sales growth.

“With lockdown restrictions now easing, we are clearly seeing pent-up demand flow through into forward bookings.”

In June Silk achieved a 60 store milestone. The business has opened three new clinics in this financial year so far, and on 31 August 2021 finalised the acquisition of the ASC Group, comprising Australian Skin Clinics
and The Cosmetic Clinic in New Zealand.

The Silk clinic network is now 118 clinics.

“This acquisition cements Silk’s position as a major player in the Australian non-surgical aesthetic industry and supports our offshore expansion,” Perelman said.

“We have already met many of our new franchise partners and we’re looking forward to delivering on the strategic benefits we see from bringing the businesses together.

“We continue to provide our clients with more choice, more innovation and most importantly, better
service and results.”

Silk’s service mix continues to evolve as the chain steps up the injectable and body categories.